Vascular Dementia: Clinical Trials

13 trials for Vascular Dementia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 5 completed, 1 withdrawn. 13 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Unknown 7, Completed 5, Withdrawn 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow Vascular Dementia: new trials by email Literature Review of Vascular Dementia trials Research Report on Vascular Dementia

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia
Tian Ma Bian Chun Zhi Gan Tablets, Placebo - Vascular Dementia, Cognitive Impairment
Phase 2UnknownDongzhimen Hospital, Beijing3602022-05-252022-11-22
A Noval Tau Tracer in Young Onset Dementia
18F-PM-PBB3 - Alzheimer's Disease, Vascular Dementia
Phase 1 / Phase 2UnknownChang Gung Memorial Hospital1002020-02-202020-01-30
Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment
Remote ischemic conditioning - Vascular Dementia, Cerebral Small Vessel Diseases
Phase 2UnknownUniversity of Calgary242019-09-262022-06-09
Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia
TMBCZG, placebo - Vascular Dementia
Phase 2CompletedDongzhimen Hospital, Beijing1602017-07-282021-03-02
BAC in Patient With Alzheimer's Disease or Vascular Dementia
BAC, BAC Matched Vehicle - Alzheimer's Disease, Vascular Dementia
Phase 2WithdrawnBotanicure Co., Ltd.2017-01-302026-05-20
n-3 PUFA for Vascular Cognitive Aging
Omega 3 PUFA, Placebo - Age Related Cognitive Decline, Alzheimer's Disease
Phase 2UnknownOregon Health and Science University1022014-05-012020-09-04
Symptomatic Treatment of Vascular Cognitive Impairment
Galantamine, Methylphenidate, Placebo - Mild Cognitive Impairment (Vascular), Mild Cognitive Disorder (Vascular)
Phase 2 / Phase 3UnknownAmsterdam UMC, location VUmc302014-02-012016-05-02
Effect of Insulin Sensitizer Metformin on AD Biomarkers
Metformin, Placebos - Alzheimer's Disease, Vascular Dementia
Phase 2CompletedUniversity of Pennsylvania202013-01-012017-09-21
Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia
Fufangdanshen Tablets, Placebo - Vascular Dementia
Phase 2CompletedDongzhimen Hospital, Beijing2402012-09-012018-10-23
Delta-THC in Dementia
delta-9-tetrahydrocannabinol (delta-THC), Placebo, Acetaminophen - Behavioural Disturbances, Pain
Phase 2CompletedRadboud University Medical Center502012-06-012014-06-30
The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
high dose group of SaiLuoTong capsule, low dose group of SaiLuoTong, the control group - Vascular Dementia
Phase 2UnknownShineway Pharmaceutical Co.,Ltd3722011-12-012014-05-08
Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity
Zydena (Udenafil), Placebo - Vascular Dementia, Subcortical Vascular Dementia
Phase 2UnknownSamsung Medical Center802011-11-012011-11-08
Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)
STA-1, Ergoloid Mesylates tablet - Vascular Dementia
Phase 2CompletedSinphar Pharmaceutical Co., Ltd2402002-03-012011-11-21

Narrower conditions

Dementia, Vascular (13)  ·  Alzheimer Disease (5)  ·  Cognitive Dysfunction (3)  ·  Dementia (3)  ·  Memory Disorders (2)  ·  Cerebral Small Vessel Diseases (1)  ·  Marijuana Abuse (1)  ·  Mental Disorders (1)  ·  Neurocognitive Disorders (1)  ·  Pain (1)  ·  Stroke (1)

Broader conditions

Arterial Occlusive Diseases (13)  ·  Arteriosclerosis (13)  ·  Brain Diseases (13)  ·  Cardiovascular Diseases (13)  ·  Central Nervous System Diseases (13)  ·  Cerebrovascular Disorders (13)  ·  Intracranial Arterial Diseases (13)  ·  Intracranial Arteriosclerosis (13)  ·  Leukoencephalopathies (13)  ·  Nervous System Diseases (13)  ·  Vascular Diseases (13)  ·  Mental Disorders (12)  ·  Neurocognitive Disorders (12)  ·  Dementia (10)  ·  Neurodegenerative Diseases (5)

Interventions

Acetaminophen (1)  ·  Dronabinol (1)  ·  Ergoloid Mesylates (1)  ·  Fish Oils (1)  ·  Galantamine (1)  ·  Metformin (1)  ·  Methylphenidate (1)  ·  Soybean Oil (1)  ·  nabiximols (1)  ·  udenafil (1)

Sponsors

Dongzhimen Hospital, Beijing (3)  ·  Amsterdam UMC, location VUmc (1)  ·  Botanicure Co., Ltd. (1)  ·  Chang Gung Memorial Hospital (1)  ·  Oregon Health and Science University (1)  ·  Radboud University Medical Center (1)  ·  Samsung Medical Center (1)  ·  Shineway Pharmaceutical Co.,Ltd (1)  ·  Sinphar Pharmaceutical Co., Ltd (1)  ·  University of Calgary (1)  ·  University of Pennsylvania (1)

Countries

China (5)  ·  Netherlands (2)  ·  United States (2)  ·  Canada (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Baojun Wang, Doctor (1)  ·  Benyan Luo, Doctor (1)  ·  Changshan Ai, Master (1)  ·  Desheng Zhou, Doctor (1)  ·  Dongdong Yang, Doctor (1)  ·  Duk L. Na, MD. PhD. (1)  ·  Eric Smith, MD (1)  ·  Gene Bowman, ND, MPH (1)  ·  Jiang Wu, Doctor (1)  ·  Jianming Lv (1)  ·  Jianping Jia, professor (1)  ·  Jimei Li, Bachelor (1)  ·  JinZhou Tian, MD,PhD (1)  ·  Jing Shi, M.D (1)  ·  Jinzhou Tian (1)

Results publications

PMID 27266867, PMID 29559423, PMID 30572524, PMID 30934894, PMID 31910895, PMID 33055122, PMID 34532852, PMID 38160357, PMID 39088212

NIH funding

R01AG043398 (1)